Melanoma cells show much smaller MEMO1-dependent variations in the MDA level than breast cancer cells, consistent with the observed smaller difference in RSL3 sensitivity between the wild type and MEMO1 knockout in melanoma (Figure 4E). The gene discussed is MEMO1; the disease is melanoma.